NYXH – nyxoah sa - ordinary shares (US:NASDAQ)

News

Publication relating to transparency notifications
Nyxoah S.A. (NASDAQ: NYXH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
Information on the total number of voting rights and shares
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com